Heart Attacks: TiGenix advances its cardiac stem-cell therapy – Labiotech.eu (blog)
Labiotech.eu (blog) |
Heart Attacks: TiGenix advances its cardiac stem–cell therapy
Labiotech.eu (blog) Belgian TiGenix NV released the phase I results of their cardiac stem–cell therapy at the Congress of the European Society of Cardiology (ESC) in London earlier this month. In July, TiGenix acquired the smaller biotech CoreTherapix with the AlloCSC-01 … |
